Oncology-specific AI platform for cancer centers.
| Date | Round | Amount |
|---|---|---|
| May 2026 | Series B Triomics raised a $22M Series B led by Battery Ventures to bring its oncology-focused AI tools to cancer centers. | $22M |
| May 2024 | Funding round San Francisco healthcare startup Triomics raised $15M from Y Combinator, Lightspeed, General Catalyst and Nexus to automate oncology workflows with GenAI. | $15M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.